Combination of oncolytic adenovirotherap
โ
Masayoshi Hioki; Shunsuke Kagawa; Toshiya Fujiwara; Ryo Sakai; Toru Kojima; Yuic
๐
Article
๐
2008
๐
John Wiley and Sons
๐
French
โ 292 KB
## Abstract Cancer gene therapy and oncolytic virotherapy have been studied extensively. However, their clinical application is hampered by their weak anticancer activity. We previously constructed a replicating adenovirus (OBPโ301, Telomelysin), in which the human telomerase reverse transcriptase